Patterns of DNA copy number changes in sentinel lymph node breast cancer metastases

Cytogenetic and Genome Research

Volumn 122, Issue 1, 2008, Pages 16-21

  Santos, S C L ^a   Cavalli, I J ^a   Ribeiro, E M ^a   Urban, C A ^a,b   Lima, R S ^b,c   Bleggi Torres, L F ^d   Rone, J D ^e   Haddad, B R ^e   Cavalli, L R ^e  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b HOSPITAL NOSSA SENHORA DAS GRAÇAS   (Brazil)

^c Unicenp Medical School

^d Department of Oncology ^*

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BREAST CANCER; CHROMOSOME 1; CHROMOSOME 13Q; CHROMOSOME 19; CHROMOSOME 20; CHROMOSOME 6; CHROMOSOME 6Q; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENETIC CORRELATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

ADULT; AGED; BREAST NEOPLASMS; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; GENE DOSAGE; HUMANS; KARYOTYPING; LYMPHATIC METASTASIS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 54249124086     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151311     Document Type: Article

References (30)

1. Abdul-Rasool S, Kidson SH, Panieri E, Dent D, Pillay K, Hanekom GS: An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes. J Clin Pathol 59:289-297 (2006).
2. Adeyinka A, Mertens F, Ivall I, Bondenson L, Garne JP, et al: Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation. Cancer Genet Cytogenet 118:42-47 (2000).
3. Ahr A, Holtrich U, Solbach C, Scharl A, Strebhardt K, et al: Molecular classification of breast cancer patients by gene expression profiling. J Pathol 195:312-320 (2001).
4. Arnerlov C, Emdin S, Cajander S, Bengtsson N, Tavelin B, Roos G: Intratumor variations in DNA ploidy and S-phase fraction in human breast cancer. Anal Cell Pathol 23:21-28 (2001).
5. Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, et al: Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 110:94-102 (1999).
6. Aubele M, Auer G, Nährig J, Zitzelsberger H, Quintanilla-Martinez L, et al: Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients. Anal Cell Pathol 24:77-87 (2002).
7. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adélaïde J, et al: Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 9:2981-2991 (2000).
8. Blumencranz P, Whitworth PW, Deck K, Rosenberg A, Reintgen D, et al: Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 194:426-432 (2007).
9. Cavalli LR, Urban CA, Dai D, de Assis S, Tavares DC, et al: Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared to their corresponding primary breast tumors. Cancer Genet Cytogenet 146:33-40 (2003).
10. Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, et al: Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103:1581-1586 (2005).
11. Chen LC, Kurisu W, Ljung BM, Goldman ES, Moore D 2nd, Smith HS: Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84:506-510 (1992).
12. Domenech A, Benitez A, Bajén MT, Pla MJ, Gil M, Martin-Comin J: Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: A follow-up study of up to 5 years. Oncology 72:27-32 (2007).
13. Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, et al: Molecular detection of micrometastatic breast cancer in histopathologynegative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg 239:828-837 (2004).
14. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, et al: Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100:1110-1122 (2004).
15. Hayes DF: Prognostic and predictive factors revisited. Breast 14:493-499 (2005).
16. Hunter KW: Host genetics and tumour metastasis. Br J Cancer 90:752-755 (2004).
17. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, et al: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57:1597-1604 (1997).
18. Mabry H, Giuliano AE: Sentinel node mapping for breast cancer: progress to date and prospects for the future. Surg Oncol Clin N Am 16:55-70 (2007).
19. Nathanson SD, Slater R, Debryn D, Kapke A, Linden M: Her-2/neu expression in primary breast cancer with sentinel lymph node metastasis. Ann Surg Oncol 13:205-213 (2006).
20. Nishizaki T, DeVries S, Chew K, Goodson WH 3rd, Ljung BM, et al: Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 19:267-272 (1997).
21. Nissan A, Jager D, Roystacher M, Prus D, Peretz T, et al: Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer 94:681-685 (2006).
22. Pandis N, Bardi G, Jin Y, Dietrich C, Johansson B, et al: Unbalanced t(1; 16) as the sole karyotypic abnormality in a breast carcinoma and its lymph node metastasis. Cancer Genet Cytogenet 75:158-159 (1994).
23. Pandis N, Teixeira MR, Adeyinka A, Rizou H, Bardi G, et al: Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosomes Cancer 22:122-129 (1998).
24. Patani NR, Dwek MV, Douek M: Predictors of axillary lymph node metastasis in breast cancer: a systematic review. Eur J Surg Oncol 33:409-419 (2007).
25. Reed W, Bøhler PJ, Sandstad B, Nesland JM: Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Breast J 10:174-180 (2004).
26. Teixeira MR, Pandis N, Gerdes AM, Dietrich CU, Bardi G, et al: Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer. Breast Cancer Res Treat 38:177-182 (1996).
27. Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, Teixeira MR: Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res Treat 102:143-155 (2007).
28. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536 (2002).
29. Veronesi U, Paganelli G, Vialle G, Luini A, Zurrida S, et al: Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983-990 (2006).
30. Zhu L, Loo WT, Cheng CW, Chow LW: Possible predictive markers related to micro-metastasis in breast cancer patients. Oncol Rep 15:1217-1223 (2006).